Niche Rehabilitation Target hospital systems and rehabilitation centers focusing on neurology and spinal injury to introduce ReJoyce, ReTouch, and ReGrasp as complementary devices for post-stroke and spinal cord rehabilitation, highlighting a compact team and personalized demonstrations.

US Market Entry Leverage the May 2022 ReGrasp Bionic Glove launch in the US to pursue US-based distributors and clinical partners for expanded access, supported by ongoing trials and regulatory-adjacent collaborations.

Financing Leverage Use prior funding milestones and government-backed investments to build credibility with potential customers and grant programs; position financing history as evidence of backing for clinical trials and device deployments.

Early-Stage Growth Align sales efforts with small team dynamics to offer high-touch training, remote support, and turnkey implementation for facilities seeking cost-effective, scalable neurorehabilitation solutions.

Quality & Trials Promote Prelivia and related safety-focused technology as value-adds for patient safety programs, quality improvement initiatives, and pressure injury prevention initiatives within care settings.